If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Taltz ® (ixekizumab) injection
80 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Does Taltz® (ixekizumab) affect fertility?
No effects on reproductive organs, menstrual cycle length, or sperm analysis were observed in sexually mature cynomolgus monkeys that received ixekizumab for 13 weeks at a weekly subcutaneous dose of 50 mg/kg.
Detailed Information
No effects were observed in sexually mature cynomolgus monkeys that were administered ixekizumab for 13 weeks at a subcutaneous dose of 50 mg/kg/week (at least 19 times the maximum recommended human dose on a mg/kg basis) regarding
- reproductive organs
- menstrual cycle length, or
- sperm analysis.1
The monkeys were not mated to evaluate fertility.1
Enclosed Prescribing Information
Reference
1Taltz [package insert]. Indianapolis, IN: Eli Lilly and Company; 2024.
Date of Last Review: October 21, 2024